Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT).

Clinica chimica acta; international journal of clinical chemistry - 2 Apr 2010

Ojeda-Fernandez Luisa, Barrios Laura, Rodriguez-Barbero Alicia, Recio-Poveda Lucia, Bernabeu Carmelo, Botella Luisa M

Abstract excerpt

BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT; OMIM 187300) is an autosomal dominant vascular disorder characterized by telangiectases and internal arteriovenous malformations caused by mutations in certain elements of the TGF-beta receptor complex. In the case of HHT1 mutations in the e...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiopoietin-2
Share to Discriminant Analysis
Share to Endoglin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enzyme-Linked Immunosorbent Assay

Share to Receptors, Cell Surface

Share to Solubility

Share to Telangiectasia, Hereditary Hemorrhagic

Share to Transforming Growth Factor beta

Source

Identifiers

PMID: 20067780
DOI: 10.1016/j.cca.2009.12.023

Genes

SMAD4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20067780-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT).PMID 20067780Read ↗

Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1.Semantic proximity Read ↗

Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.Semantic proximity Read ↗

Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.Semantic proximity Read ↗

Hereditary haemorrhagic telangiectasia: a clinical and scientific review.Semantic proximity Read ↗

"Recent Advances in Hereditary Hemorrhagic Telangiectasia Pathogenesis and Therapies"Semantic proximity Read ↗

Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia.Semantic proximity Read ↗

Hereditary haemorrhagic telangiectasia: a rare disease as a model for the study of human atherosclerosis.Semantic proximity Read ↗

Global gene expression profiling of telangiectasial tissue from patients with hereditary hemorrhagic telangiectasia.Semantic proximity Read ↗

Hereditary Haemorrhagic Telangiectasia (HHT): genetic and molecular aspects.Semantic proximity Read ↗

Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new eraSemantic proximity Read ↗

Mutation analysis in Spanish patients with hereditary hemorrhagic telangiectasia: deficient endoglin up-regulation in activated monocytes.Semantic proximity Read ↗

Genetic abnormalities in hereditary hemorrhagic telangiectasia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.